Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Review Article

Promises of Lipid-based Drug Delivery Systems in the Management of Breast Cancer

Author(s): Nagarani Thotakura, Madan M. Gupta*, Jitendra S. Rajawat and Kaisar Raza*

Volume 27, Issue 45, 2021

Published on: 27 July, 2021

Page: [4568 - 4577] Pages: 10

DOI: 10.2174/1381612827666210728104318

Price: $65

Abstract

Breast cancer is one of the leading types among the common non-cutaneous malignancies in women. All the curative methods available for its treatment are minimal due to their toxicity issues and dose-related side effects. Various evolving nanotechnology techniques displayed the opportunity to target breast cancer. One such delivery system is lipid-based drug delivery systems (LDDS). This concept is constrained only for the laboratory scale should be shifted to the industrial level targeting the nanomedicine with clinical benefits. This work tried to portray the advancements in the LDDS along with the lipid-based excipients, advantages, disadvantages and applications. It even helped in highlighting the recently developed lipid-based nanocarriers for breast cancer management.

Keywords: Liposomes, lipospheres, lipid polymer hybrid nanoparticles, nanostructured lipid carriers, solid lipid nanoparticles, tumor.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy